PKS Advisory Services’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$42K	Hold	10,500	–	–	0.01%	259
2025 Q1	$33.4K	Hold	10,500	–	–	0.01%	241
2024 Q4	$56.2K	Buy	+10,500	New	+$56.2K	0.01%	243